Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News ImmuCell Corporation ICCC

ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The firm has developed products that provide immediate immunity to newborn dairy and beef cattle and is developing product line extensions of its existing products that address mastitis. Its lead product, First Defense, is manufactured to prevent scours in newborn calves. The company generates the majority of its revenue from the United States.

The Power Play by The Market Herald
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Stock Price Chart (NDAQ:ICCC)

Fundamentals Snapshot (NDAQ:ICCC)

Opinion & Analysis (NDAQ:ICCC)

No current opinion is available.

Bullboard Posts (NDAQ:ICCC)

it's a buy today for me

at these low prices,so glta shareholders.
coolfooldumbguy - January 21, 2020

trading at book

not a lot of assets that i can find
Craven_Morhead - August 26, 2010

Interview with Mike Brigham

CEO of ImmuCell Corporation, Mike Brigham's interview is now online at Wall Street Reporter website
StockMaster1 - April 25, 2007

DiffGAM

ImmuCell Announces Positive Preliminary Results From Clinical Trial of DiffGAM PORTLAND, Maine--(BW HealthWire)--March 28, 2000...
trade100 - March 28, 2000

TIPS

INP(TSE) 3.12 TO HIT 4.50 MBC(CDNX) 0.41 TO HIT 0.85 MRS(TSE) 3.60 TO HIT 10.00 LII(NYSE) 9.62 TO HIT 15.00 TDE(TSE) 0.16 TO HIT 0.50...
trade100 - March 20, 2000